DNA vaccination against oncoantigens

SCA-1 Identifies the Tumor-Initiating Cells in Mammary Tumors of BALB-neuT Transgenic Mice

(2015) Cristina Grange et al.   NEOPLASIA

DNA fusion vaccines enter the clinic

(2011) Freda K. Stevenson et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

2011: the immune hallmarks of cancer

(2011) Federica Cavallo et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Vaccines and Other Immunological Approaches for Cancer Immunoprevention

(2011) Pier-Luigi Lollini et al.   CURRENT DRUG TARGETS

Plasmid DNA Gene Therapy by Electroporation: Principles and Recent Advances

(2011) Tatsufumi Murakami et al.   CURRENT GENE THERAPY

HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy

(2011) Ilaria Grazia Zizzari et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Response to self antigen imprints regulatory memory in tissues

(2011) Michael D. Rosenblum et al.   NATURE

Chondroitin sulfate proteoglycan-4: A biomarker and a potential immunotherapeutic target for canine malignant melanoma

(2011) Saray Lorda Mayayo et al.   VETERINARY JOURNAL

Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans

(2011) Elena Quaglino et al.   Cancers

Combining Human and Rat Sequences in Her-2 DNA Vaccines Blunts Immune Tolerance and Drives Antitumor Immunity

(2010) J. B. Jacob et al.   CANCER RESEARCH

A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins

(2010) Elena Quaglino et al.   CANCER RESEARCH

CSPG4 in Cancer: Multiple Roles

(2010) X. Wang et al.   CURRENT MOLECULAR MEDICINE

Erbb2 DNA Vaccine Combined with Regulatory T Cell Deletion Enhances Antibody Response and Reveals Latent Low-Avidity T Cells: Potential and Limits of Its Therapeutic Efficacy

(2010) S. Rolla et al.   JOURNAL OF IMMUNOLOGY

DAI (DLM-1/ZBP1) as a Genetic Adjuvant for DNA Vaccines That Promotes Effective Antitumor CTL Immunity

(2010) Alvaro Lladser et al.   MOLECULAR THERAPY

A Novel Cancer Therapy by Skin Delivery of Indoleamine 2,3-Dioxygenase siRNA

(2009) M.-C. Yen et al.   CLINICAL CANCER RESEARCH

A Multi-DNA Preventive Vaccine for p53/Neu-Driven Cancer Syndrome

(2009) C. De Giovanni et al.   HUMAN GENE THERAPY

DNA Vaccination with Electroporation Induces Increased Antibody Responses in Patients with Prostate Cancer

(2009) Lindsey Low et al.   HUMAN GENE THERAPY

Renaissance for mouse models of human hematopoiesis and immunobiology

(2009) Markus G Manz et al.   NATURE IMMUNOLOGY

Cancer Immunotherapy

(2009) Philip J. Bergman   Topics in Companion Animal Medicine

Electrochemotherapy with Intravenous Bleomycin in the Local Treatment of Skin Melanoma Metastases

(2008) P. Quaglino et al.   ANNALS OF SURGICAL ONCOLOGY

The “A, B and C” of Her-2 DNA vaccine development

(2008) Wei-Zen Wei et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Oncoantigens as anti-tumor vaccination targets: the chance of a lucky strike?

(2008) Raffaele Adolfo Calogero et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

DNA Vaccines Targeting Tumor Antigens to B7 Molecules on Antigen-Presenting Cells Induce Protective Antitumor Immunity and Delay Onset of HER-2/Neu-Driven Mammary Carcinoma

(2008) A. Sloots et al.   CLINICAL CANCER RESEARCH

Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignancies

(2008) R. Berger et al.   CLINICAL CANCER RESEARCH

Protective Immunity Against neu-Positive Carcinomas Elicited by Electroporation of Plasmids Encoding Decreasing Fragments of Rat Neu Extracellular Domain

(2008) Simona Rolla et al.   HUMAN GENE THERAPY

The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination

(2008) Roberto Chiarle et al.   NATURE MEDICINE